News
DMC Global (BOOM) Reports Q4 Earnings: What Key Metrics Have to Say
DMC Global (BOOM) reported $143.53 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 5.8%. EPS of -$0.50 for the same period compares to $0.09 a year
Compared to Estimates, Skyward (SKWD) Q4 Earnings: A Look at Key Metrics
Skyward Specialty Insurance (SKWD) reported $385.59 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 26.7%. EPS of $1.17 for the same period compares
Compared to Estimates, ProAssurance (PRA) Q4 Earnings: A Look at Key Metrics
ProAssurance (PRA) reported $271.56 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 5.6%. EPS of $0.82 for the same period compares to $0.36 a year
Compared to Estimates, BioMarin (BMRN) Q4 Earnings: A Look at Key Metrics
BioMarin Pharmaceutical (BMRN) reported $874.57 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 17%. EPS of $0.46 for the same period compares to
Skyward Specialty Insurance (SKWD) Q4 Earnings and Revenues Surpass Estimates
Skyward Specialty Insurance (SKWD) came out with quarterly earnings of $1.17 per share, beating the Zacks Consensus Estimate of $0.96 per share. This compares to earnings of $0.8 per share a year
Ultra Clean Holdings (UCTT) Misses Q4 Earnings and Revenue Estimates
Ultra Clean Holdings (UCTT) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.51 per share a year ago
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates
Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.6 per share a year ago
V2X (VVX) Tops Q4 Earnings and Revenue Estimates
V2X (VVX) came out with quarterly earnings of $1.56 per share, beating the Zacks Consensus Estimate of $1.33 per share. This compares to earnings of $1.33 per share a year ago. These figures are
Si-Bone (SIBN) Reports Q4 Loss, Tops Revenue Estimates
Si-Bone (SIBN) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.11 per share a year ago. These figures are
Paymentus (PAY) Q4 Earnings and Revenues Surpass Estimates
Paymentus (PAY) came out with quarterly earnings of $0.2 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.13 per share a year ago. These figures
Offerpad Solutions Inc. (OPAD) Reports Q4 Loss, Lags Revenue Estimates
Offerpad Solutions Inc. (OPAD) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.63 per share a year ago. These
ProAssurance (PRA) Q4 Earnings and Revenues Surpass Estimates
ProAssurance (PRA) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.22 per share. This compares to earnings of $0.36 per share a year ago. These
Ryman Hospitality Properties (RHP) Q4 FFO and Revenues Beat Estimates
Ryman Hospitality Properties (RHP) came out with quarterly funds from operations (FFO) of $2.38 per share, beating the Zacks Consensus Estimate of $2.22 per share. This compares to FFO of $2.15 per
Myriad Genetics (MYGN) Q4 Earnings and Revenues Surpass Estimates
Myriad Genetics (MYGN) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to earnings of $0.03 per share a year
Quaker Chemical (KWR) Lags Q4 Earnings Estimates
Quaker Chemical (KWR) came out with quarterly earnings of $1.65 per share, missing the Zacks Consensus Estimate of $1.71 per share. This compares to earnings of $1.33 per share a year ago. These
Innovex International (INVX) Lags Q4 Earnings Estimates
Innovex International (INVX) came out with quarterly earnings of $0.2 per share, missing the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.47 per share a year ago
MediaAlpha, Inc. (MAX) Q4 Earnings Beat Estimates
MediaAlpha, Inc. (MAX) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.08 per share a year ago. These
JBT Marel (JBTM) Q4 Earnings and Revenues Beat Estimates
JBT Marel (JBTM) came out with quarterly earnings of $1.98 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $1.7 per share a year ago. These figures
Hims & Hers Health, Inc. (HIMS) Surpasses Q4 Earnings Estimates
Hims & Hers Health, Inc. (HIMS) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to earnings of $0.11 per share a year ago
Innovative Industrial Properties (IIPR) Q4 FFO and Revenues Top Estimates
Innovative Industrial Properties (IIPR) came out with quarterly funds from operations (FFO) of $1.88 per share, beating the Zacks Consensus Estimate of $1.81 per share. This compares to FFO of $2.22
Claritev Corporation (CTEV) Reports Q4 Loss, Tops Revenue Estimates
Claritev Corporation (CTEV) came out with a quarterly loss of $4.88 per share versus the Zacks Consensus Estimate of a loss of $3.96. This compares to a loss of $5.14 per share a year ago. These
HealthStream (HSTM) Tops Q4 Earnings and Revenue Estimates
HealthStream (HSTM) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.16 per share a year ago. These
Great Lakes Dredge & Dock (GLDD) Q4 Earnings and Revenues Beat Estimates
Great Lakes Dredge & Dock (GLDD) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.2 per share. This compares to earnings of $0.29 per share a year ago
DMC Global (BOOM) Reports Q4 Loss, Beats Revenue Estimates
DMC Global (BOOM) came out with a quarterly loss of $0.5 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to earnings of $0.09 per share a year ago. These figures are
BioMarin Pharmaceutical (BMRN) Beats Q4 Earnings and Revenue Estimates
BioMarin Pharmaceutical (BMRN) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to earnings of $0.92 per share a year ago


